|
Category Archives: AZBio News
Helios Scholars at TGen learn teamwork, technique and tenacity
Symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education FoundationContinue reading
First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials
The Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), in partnership with Parkinson’s UK, announces that the European Medicines Agency (EMA) has issued a positive qualification opinion on an imaging test (biomarker) as a tool to enrich Parkinson’s clinical trials. The purpose of this enrichment biomarker is to serve as a measurement that can be used to select people with Parkinson’s who are most suitable to take part in clinical trials.Continue reading
UA Clinical Trial to Repurpose Ketamine for Parkinson’s Patients
The best-known treatment for Parkinson’s disease isn’t perfect. Named levodopa, the drug can treat the stiffness and slowness of movement associated with the debilitating disease.Continue reading
House Bill to Repeal the Medical Device Tax Passes with Strong Bi-Partisan Support.
H.R. 184 the Protect Medical Innovation Act which would repeal the Medical Device Excise Tax passed in the U.S House of Representatives on July 24, 2018. (283 Ayes; 132 Nayes; 13 Not Voting) Seven members of Arizona’s nine person House Delegation both co-sponsored and voted in support of of the bill. The next step is the Senate. Continue reading
TGen-led study shows mutated gene is likely cause of a 3-year old girl’s severe disorder
Damaged gene FBXO28 is linked to patient at TGen’s Center for Rare Childhood DisordersContinue reading
The Fostering Innovation Act and the HALOS Act pass in the U.S. House of Representatives
The House of Representatives on July 17, 2018 passed two bills designed to better equip job creators in our state to grow and thrive.Continue reading
TGen-led study shows DNA methylation related to liver disease among obese patients
Potentially deadly NAFLD associated with genetic changes; potential drug targets identifiedContinue reading
TGen opens DIPG tissue donation portal to accelerate research
New donations support research into this fast-moving brain cancerContinue reading